Company Offering
SEC Accession #
0001665160-19-000598
Filing Date
Investment Security Details
Submission
C-AR/A
Investing Platform Detail
Offering Company Details
Executive Signatory
Charles S. Cotropia
Title
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer
Website
www.bioclonetics.com
Employee Count at Offering
4
SEC CIK
1701251
FILE NUMBER
020-23301
Comments